Book Highlights ~ Bentham Books

Exploring New Ways to Treat Different Cancers

News Release Date: Jun 19, 2019

This book is Authored by: Atta-ur-Rahman and M. Iqbal Choudhary, Published on: 31-May-19.


Book Website


Bentham Science's premier Anti-cancer drug discovery book series is now in its 10th volume.

Frontiers in Anti-Cancer Drug Discovery is one of the first drug discovery book series published by Bentham Science. The series is Edited by Dr. Atta-ur-Rahman, and M. Iqbal Choudhary. The tenth volume of the series features chapters covering the treatment and management of specific tumors such as hepatoblastoma and glioblastoma, the reole of different transporters and nanocarriers in anti-cancer medicine, advances in anti-cancer nanomedicine and polyphenols. The series continues to be an up-to-date source of information for pharmaceutical researchers, oncologists and molecular biologists studying cancer and devising treatment solutions for patients embattled with the disease.


About the Editors:


Dr. Atta-ur-Rahman

Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1142 international publications in several fields of organic chemistry including 775 research publications, 43 international patents, 70 chapters in books and 256 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products "Studies in Natural Product Chemistry" 60 volumes of which have been published under his Editorship by Elsevier during the last two decades.


Dr. M. Iqbal Choudhary

M. Iqbal Choudhary is a Ph. D. scientist in the field of organic chemistry from Pakistan working at the University of Karachi. He is known for his research in bioorganic chemistry and natural product chemistry. He has more than 900 research publications, including 33 books published.


Keywords: Hepatoblastoma, Monocarboxylate Transporter-1, Mesoporous Nanocarriers, polyphenols, chemotherapy, nanomedicine, anti-cancer agents